BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-88. [PMID: 20975743 DOI: 10.1038/nrendo.2010.189] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Chou JY, Jun HS, Mansfield BC. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J Inherit Metab Dis 2015;38:511-9. [DOI: 10.1007/s10545-014-9772-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
2 Zhou J, Waskowicz LR, Lim A, Liao XH, Lian B, Masamune H, Refetoff S, Tran B, Koeberl DD, Yen PM. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia. Thyroid 2019;29:1158-67. [PMID: 31337282 DOI: 10.1089/thy.2019.0007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
3 Jawale CV, Ramani K, Li DD, Coleman BM, Oberoi RS, Kupul S, Lin L, Desai JV, Delgoffe GM, Lionakis MS, Bender FH, Prokopienko AJ, Nolin TD, Gaffen SL, Biswas PS. Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease. Sci Transl Med 2020;12:eaay5691. [PMID: 32554707 DOI: 10.1126/scitranslmed.aay5691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Kwon JH, Lee YM, Cho JH, Kim GY, Anduaga J, Starost MF, Mansfield BC, Chou JY. Liver-directed gene therapy for murine glycogen storage disease type Ib. Hum Mol Genet 2017;26:4395-405. [PMID: 28973635 DOI: 10.1093/hmg/ddx325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kern L, Spreckels J, Nist A, Stiewe T, Skevaki C, Greene B, Mernberger M, Elsässer HP. Altered glycogen metabolism causes hepatomegaly following an Atg7 deletion. Cell Tissue Res 2016;366:651-65. [PMID: 27553638 DOI: 10.1007/s00441-016-2477-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pan CJ, Chen SY, Jun HS, Lin SR, Mansfield BC, Chou JY. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One 2011;6:e23157. [PMID: 21949678 DOI: 10.1371/journal.pone.0023157] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
7 Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123:2843-2853. [PMID: 24565827 DOI: 10.1182/blood-2013-05-502435] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
8 Lizák B, Szarka A, Kim Y, Choi KS, Németh CE, Marcolongo P, Benedetti A, Bánhegyi G, Margittai É. Glucose Transport and Transporters in the Endomembranes. Int J Mol Sci 2019;20:E5898. [PMID: 31771288 DOI: 10.3390/ijms20235898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
9 Lee YM, Kim GY, Pan CJ, Mansfield BC, Chou JY. Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia. Mol Genet Metab Rep 2015;3:28-32. [PMID: 26937391 DOI: 10.1016/j.ymgmr.2015.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Lee YM, Jun HS, Pan CJ, Lin SR, Wilson LH, Mansfield BC, Chou JY. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology 2012;56:1719-29. [PMID: 22422504 DOI: 10.1002/hep.25717] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
11 Lee KJ, Choi SJ, Kim WS, Park SS, Moon JS, Ko JS. Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b. Pediatr Gastroenterol Hepatol Nutr 2016;19:71-5. [PMID: 27066451 DOI: 10.5223/pghn.2016.19.1.71] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li X, Jing H, Cheng L, Xia J, Wang J, Li Q, Liu C, Cai P. A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging. Quant Imaging Med Surg 2021;11:2785-91. [PMID: 34079743 DOI: 10.21037/qims-20-746] [Reference Citation Analysis]
13 Anyamaneeratch K, Rojvirat P, Sukjoi W, Jitrapakdee S. Insights into Transcriptional Regulation of Hepatic Glucose Production. Elsevier; 2015. pp. 203-53. [DOI: 10.1016/bs.ircmb.2015.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
14 Hayee B, Antonopoulos A, Murphy EJ, Rahman FZ, Sewell G, Smith BN, McCartney S, Furman M, Hall G, Bloom SL, Haslam SM, Morris HR, Boztug K, Klein C, Winchester B, Pick E, Linch DC, Gale RE, Smith AM, Dell A, Segal AW. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology 2011;21:914-24. [PMID: 21385794 DOI: 10.1093/glycob/cwr023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
15 Kang HR, Waskowicz L, Seifts AM, Landau DJ, Young SP, Koeberl DD. Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia. Mol Ther Methods Clin Dev 2019;13:265-73. [PMID: 30859111 DOI: 10.1016/j.omtm.2019.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Choi R, Park HD, Ko JM, Lee J, Lee DH, Hong SJ, Ki CS, Lee SY, Kim JW, Song J, Choe YH. Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib. Ann Lab Med 2017;37:261-6. [PMID: 28224773 DOI: 10.3343/alm.2017.37.3.261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ramamonjisoa N, Ratiney H, Mutel E, Guillou H, Mithieux G, Pilleul F, Rajas F, Beuf O, Cavassila S. In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a. J Lipid Res 2013;54:2010-22. [PMID: 23596325 DOI: 10.1194/jlr.D033399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Roseman DS, Khan T, Rajas F, Jun LS, Asrani KH, Isaacs C, Farelli JD, Subramanian RR. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a. Mol Ther 2018;26:814-21. [PMID: 29428299 DOI: 10.1016/j.ymthe.2018.01.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
19 Almodóvar-Payá A, Villarreal-Salazar M, de Luna N, Nogales-Gadea G, Real-Martínez A, Andreu AL, Martín MA, Arenas J, Lucia A, Vissing J, Krag T, Pinós T. Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models. Int J Mol Sci 2020;21:E9621. [PMID: 33348688 DOI: 10.3390/ijms21249621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Penhoat A, Mutel E, Amigo-correig M, Pillot B, Stefanutti A, Rajas F, Mithieux G. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiology & Behavior 2011;105:89-93. [DOI: 10.1016/j.physbeh.2011.03.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
21 Shen Y, Hong H, Sangwung P, Lapping S, Nayak L, Zhang L, Jain MK, Liao X. Kruppel-like factor 4 regulates neutrophil activation. Blood Adv 2017;1:662-8. [PMID: 29296708 DOI: 10.1182/bloodadvances.2017004341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Biosse Duplan M, Hubert A, Le Norcy E, Louzoun A, Perry A, Chaussain C, Labrune P. Dental and periodontal manifestations of glycogen storage diseases: a case series of 60 patients. J Inherit Metab Dis. 2018;41:947-953. [PMID: 29663268 DOI: 10.1007/s10545-018-0182-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
23 Boers SJ, Visser G, Smit PG, Fuchs SA. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis. 2014;9:47. [PMID: 24716823 DOI: 10.1186/1750-1172-9-47] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
24 Chaturvedi S, Singh AK, Keshari AK, Maity S, Sarkar S, Saha S. Human Metabolic Enzymes Deficiency: A Genetic Mutation Based Approach. Scientifica (Cairo) 2016;2016:9828672. [PMID: 27051561 DOI: 10.1155/2016/9828672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
25 Lu SQ, Feng JY, Liu J, Xie XB, Lu Y, Abuduxikuer K. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review. J Pediatr Endocrinol Metab 2020;33:1321-33. [PMID: 32892177 DOI: 10.1515/jpem-2020-0173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zeigerer A, Bogorad RL, Sharma K, Gilleron J, Seifert S, Sales S, Berndt N, Bulik S, Marsico G, D'Souza RCJ, Lakshmanaperumal N, Meganathan K, Natarajan K, Sachinidis A, Dahl A, Holzhütter HG, Shevchenko A, Mann M, Koteliansky V, Zerial M. Regulation of liver metabolism by the endosomal GTPase Rab5. Cell Rep 2015;11:884-92. [PMID: 25937276 DOI: 10.1016/j.celrep.2015.04.018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
27 Cho JH, Lee YM, Bae SH, Chou JY. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia. Biochem Biophys Res Commun 2020;522:1-7. [PMID: 31735334 DOI: 10.1016/j.bbrc.2019.11.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cappello AR, Curcio R, Lappano R, Maggiolini M, Dolce V. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family. Front Chem 2018;6:122. [PMID: 29719821 DOI: 10.3389/fchem.2018.00122] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
29 Kasapkara ÇS, Cinasal Demir G, Hasanoğlu A, Tümer L. Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 2014;68:101-5. [PMID: 24149443 DOI: 10.1038/ejcn.2013.186] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
30 Clar J, Gri B, Calderaro J, Birling MC, Hérault Y, Smit GP, Mithieux G, Rajas F. Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy. Kidney Int 2014;86:747-56. [PMID: 24717294 DOI: 10.1038/ki.2014.102] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
31 Antonopoulos A, North S, Haslam S, Dell A. Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses. Biochemical Society Transactions 2011;39:1334-40. [DOI: 10.1042/bst0391334] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
32 Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, Christ E, Baumgartner MR, Hochuli M. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I – A link to metabolic control. Molecular Genetics and Metabolism 2018;125:73-8. [DOI: 10.1016/j.ymgme.2018.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Iizuka K. The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer. Biochim Biophys Acta Mol Basis Dis 2017;1863:474-85. [PMID: 27919710 DOI: 10.1016/j.bbadis.2016.11.029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
34 Yıldız Y, Sivri HS. Inborn errors of metabolism in the differential diagnosis of fatty liver disease. Turk J Gastroenterol 2020;31:3-16. [PMID: 32009609 DOI: 10.5152/tjg.2019.19367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
35 Chou JY, Cho JH, Kim GY, Mansfield BC. Molecular biology and gene therapy for glycogen storage disease type Ib. J Inherit Metab Dis 2018;41:1007-14. [PMID: 29663270 DOI: 10.1007/s10545-018-0180-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
36 Iizuka Y, Chiba K, Kim H, Hirako S, Wada M, Matsumoto A. Impact of discontinuation of fish oil after pioglitazone–fish oil combination therapy in diabetic KK mice. The Journal of Nutritional Biochemistry 2020;76:108265. [DOI: 10.1016/j.jnutbio.2019.108265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
37 Connor T, Martin SD, Howlett KF, Mcgee SL. Metabolic remodelling in obesity and type 2 diabetes: pathological or protective mechanisms in response to nutrient excess? Clin Exp Pharmacol Physiol 2015;42:109-15. [DOI: 10.1111/1440-1681.12315] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
38 Rajas F, Clar J, Gautier-Stein A, Mithieux G. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease. J Inherit Metab Dis 2015;38:521-7. [PMID: 25164786 DOI: 10.1007/s10545-014-9761-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
39 Kim GY, Kwon JH, Cho JH, Zhang L, Mansfield BC, Chou JY. Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Hum Mol Genet 2017;26:1890-9. [PMID: 28334808 DOI: 10.1093/hmg/ddx097] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
40 Sambuceti G, Cossu V, Bauckneht M, Morbelli S, Orengo A, Carta S, Ravera S, Bruno S, Marini C. 18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at? Eur J Nucl Med Mol Imaging 2021;48:1278-86. [PMID: 33864142 DOI: 10.1007/s00259-021-05368-2] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Wang Z, Dong C. Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase. Trends Cancer 2019;5:30-45. [PMID: 30616754 DOI: 10.1016/j.trecan.2018.11.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 19.3] [Reference Citation Analysis]
42 Kanungo S, Wells K, Tribett T, El-Gharbawy A. Glycogen metabolism and glycogen storage disorders. Ann Transl Med 2018;6:474. [PMID: 30740405 DOI: 10.21037/atm.2018.10.59] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
43 Deng Y, Wang ZV, Tao C, Gao N, Holland WL, Ferdous A, Repa JJ, Liang G, Ye J, Lehrman MA, Hill JA, Horton JD, Scherer PE. The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism. J Clin Invest 2013;123:455-68. [PMID: 23257357 DOI: 10.1172/JCI62819] [Cited by in Crossref: 93] [Cited by in F6Publishing: 59] [Article Influence: 10.3] [Reference Citation Analysis]
44 Wan J, Zhang ZC, Yang MQ, Sun XM, Yin L, Chen CQ. Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report. World J Clin Cases 2021;9:4342-7. [PMID: 34141799 DOI: 10.12998/wjcc.v9.i17.4342] [Reference Citation Analysis]
45 Grünert SC, Elling R, Maag B, Wortmann SB, Derks TGJ, Hannibal L, Schumann A, Rosenbaum-Fabian S, Spiekerkoetter U. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet J Rare Dis 2020;15:218. [PMID: 32838757 DOI: 10.1186/s13023-020-01503-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
46 Kim GY, Lee YM, Kwon JH, Cho JH, Pan CJ, Starost MF, Mansfield BC, Chou JY. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors. Mol Genet Metab 2017;120:229-34. [PMID: 28096054 DOI: 10.1016/j.ymgme.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
47 Sim SW, Weinstein DA, Lee YM, Jun HS. Glycogen storage disease type Ib: role of glucose‐6‐phosphate transporter in cell metabolism and function. FEBS Lett 2019;594:3-18. [DOI: 10.1002/1873-3468.13666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Lee YM, Conlon TJ, Specht A, Coleman KE, Brown LM, Estrella AM, Dambska M, Dahlberg KR, Weinstein DA. Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia. J Inherit Metab Dis 2018;41:977-84. [DOI: 10.1007/s10545-018-0199-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
49 Farah BL, Landau DJ, Wu Y, Sinha RA, Loh A, Bay BH, Koeberl DD, Yen PM. Renal endoplasmic reticulum stress is coupled to impaired autophagy in a mouse model of GSD Ia. Mol Genet Metab 2017;122:95-8. [PMID: 28888852 DOI: 10.1016/j.ymgme.2017.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Mohtashami M, Razavi A, Abolhassani H, Aghamohammadi A, Yazdani R. Primary Immunodeficiency and Thrombocytopenia. Int Rev Immunol 2021;:1-43. [PMID: 33464134 DOI: 10.1080/08830185.2020.1868454] [Reference Citation Analysis]
51 Palhegyi AM, Seranova E, Dimova S, Hoque S, Sarkar S. Biomedical Implications of Autophagy in Macromolecule Storage Disorders. Front Cell Dev Biol 2019;7:179. [PMID: 31555645 DOI: 10.3389/fcell.2019.00179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
52 Resaz R, Vanni C, Segalerba D, Sementa AR, Mastracci L, Grillo F, Murgia D, Bosco MC, Chou JY, Barbieri O, Varesio L, Eva A. Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency. Dis Model Mech 2014;7:1083-91. [PMID: 25147298 DOI: 10.1242/dmm.014878] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
53 Bégin P, Patey N, Mueller P, Rasquin A, Sirard A, Klein C, Haddad E, Drouin É, Le Deist F. Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency. J Clin Immunol. 2013;33:520-525. [PMID: 23180359 DOI: 10.1007/s10875-012-9833-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
54 Colonetti K, Bento Dos Santos B, Nalin T, Moura de Souza CF, Triplett EW, Dobbler PT, Schwartz IVD, Roesch LFW. Hepatic glycogen storage diseases are associated to microbial dysbiosis. PLoS One 2019;14:e0214582. [PMID: 30939160 DOI: 10.1371/journal.pone.0214582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
55 Jorns C, Ellis EC, Nowak G, Fischler B, Nemeth A, Strom SC, Ericzon BG. Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med. 2012;272:201-223. [PMID: 22789058 DOI: 10.1111/j.1365-2796.2012.02574.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 9.2] [Reference Citation Analysis]
56 Cangelosi D, Resaz R, Petretto A, Segalerba D, Ognibene M, Raggi F, Mastracci L, Grillo F, Bosco MC, Varesio L, Sica A, Colombo I, Eva A. A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization. J Proteome Res 2019;18:2965-78. [DOI: 10.1021/acs.jproteome.9b00309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Gu L, Li X, Han Y, Zhang D, Gong Q, Zhang X. A novel homozygous no-stop mutation in G6PC gene from a Chinese patient with glycogen storage disease type Ia. Gene 2014;536:362-5. [DOI: 10.1016/j.gene.2013.11.059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
58 Resaz R, Emionite L, Vanni C, Astigiano S, Puppo M, Lavieri R, Segalerba D, Pezzolo A, Bosco MC, Oberto A, Eva C, Chou JY, Varesio L, Barbieri O, Eva A. Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair. J Hepatol 2011;55:1263-71. [PMID: 21703205 DOI: 10.1016/j.jhep.2011.02.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
59 Ng BG, Sosicka P, Fenaille F, Harroche A, Vuillaumier-Barrot S, Porterfield M, Xia ZJ, Wagner S, Bamshad MJ, Vergnes-Boiteux MC, Cholet S, Dalton S, Dell A, Dupré T, Fiore M, Haslam SM, Huguenin Y, Kumagai T, Kulik M, McGoogan K, Michot C, Nickerson DA, Pascreau T, Borgel D, Raymond K, Warad D, Flanagan-Steet H, Steet R, Tiemeyer M, Seta N, Bruneel A, Freeze HH; University of Washington Center for Mendelian Genomics (UW-CMG). A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction. Am J Hum Genet 2021;108:1040-52. [PMID: 33964207 DOI: 10.1016/j.ajhg.2021.04.013] [Reference Citation Analysis]
60 Cho JH, Kim GY, Pan CJ, Anduaga J, Choi EJ, Mansfield BC, Chou JY. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet. 2017;13:e1006819. [PMID: 28558013 DOI: 10.1371/journal.pgen.1006819] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
61 Oishi K, Arnon R, Wasserstein MP, Diaz GA. Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management. Pediatr Transplant 2016;20:756-69. [PMID: 27329540 DOI: 10.1111/petr.12741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
62 Pan D, Mao C, Wang YX. Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation. PLoS One 2013;8:e66294. [PMID: 23755305 DOI: 10.1371/journal.pone.0066294] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
63 Jun HS, Cheung YY, Lee YM, Mansfield BC, Chou JY. Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality. Blood 2012;119:4047-55. [PMID: 22246029 DOI: 10.1182/blood-2011-09-377820] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
64 Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Bosco MC, Mastracci L, Neumaier CE, Varesio L, Eva A. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. Dis Model Mech. 2019;12. [PMID: 30898969 DOI: 10.1242/dmm.038026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Kim GY, Lee YM, Cho JH, Pan CJ, Jun HS, Springer DA, Mansfield BC, Chou JY. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity. Hum Mol Genet 2015;24:5115-25. [PMID: 26089201 DOI: 10.1093/hmg/ddv230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
66 Wicker C, Roda C, Perry A, Arnoux JB, Brassier A, Castelle M, Servais A, Donadieu J, Bouchereau J, Pigneur B, Labrune P, Ruemmele FM, de Lonlay P. Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort. Mol Genet Metab Rep. 2020;23:100581. [PMID: 32300528 DOI: 10.1016/j.ymgmr.2020.100581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Miao H, Zhou J, Yang Q, Liang F, Wang D, Ma N, Gao B, Du J, Lin G, Wang K, Zhang Q. Long-read sequencing identified a causal structural variant in an exome-negative case and enabled preimplantation genetic diagnosis. Hereditas 2018;155:32. [PMID: 30279644 DOI: 10.1186/s41065-018-0069-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
68 Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Critical Reviews in Oncology/Hematology 2019;133:149-62. [DOI: 10.1016/j.critrevonc.2018.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
69 Shimizu S, Sakamoto S, Yamada M, Fukuda A, Yanagi Y, Uchida H, Mimori K, Shoji K, Funaki T, Miyairi I, Nakano N, Haga C, Yoshioka T, Imadome KI, Horikawa R, Kasahara M. Immunological features and complications in patients with glycogen storage disease 1b after living donor liver transplantation. Pediatr Transplant 2021;:e14104. [PMID: 34339091 DOI: 10.1111/petr.14104] [Reference Citation Analysis]
70 Chou JY, Mansfield BC. Recombinant AAV-directed gene therapy for type I glycogen storage diseases. Expert Opin Biol Ther 2011;11:1011-24. [PMID: 21504389 DOI: 10.1517/14712598.2011.578067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
71 Lucy M, Butler S, Garverick H. Endocrine and metabolic mechanisms linking postpartum glucose with early embryonic and foetal development in dairy cows. Animal 2014;8:82-90. [DOI: 10.1017/s1751731114000482] [Cited by in Crossref: 35] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
72 Kim GY, Lee YM, Kwon JH, Jun HS, Chou J. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration. Biochem Biophys Res Commun 2017;482:569-74. [PMID: 27864142 DOI: 10.1016/j.bbrc.2016.11.075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
73 Rajas F, Labrune P, Mithieux G. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders. Diabetes & Metabolism 2013;39:377-87. [DOI: 10.1016/j.diabet.2013.03.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
74 Hou X, Liu Q, Meng Q, Wang L, Yan H, Zhang L, Wang L. TMT-based quantitative proteomic analysis of porcine muscle associated with postmortem meat quality. Food Chem 2020;328:127133. [PMID: 32480263 DOI: 10.1016/j.foodchem.2020.127133] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
75 Waskowicz LR, Zhou J, Landau DJ, Brooks ED, Lim A, Yavarow ZA, Kudo T, Zhang H, Wu Y, Grant S, Young SP, Huat BB, Yen PM, Koeberl DD. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. Hum Mol Genet 2019;28:143-54. [PMID: 30256948 DOI: 10.1093/hmg/ddy343] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
76 Chou JY, Kim GY, Cho JH. Recent development and gene therapy for glycogen storage disease type Ia. Liver Res 2017;1:174-80. [PMID: 29576889 DOI: 10.1016/j.livres.2017.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Cho JH, Kim GY, Mansfield BC, Chou JY. Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia. Biochem Biophys Res Commun 2018;498:925-31. [PMID: 29545180 DOI: 10.1016/j.bbrc.2018.03.083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
78 Papenfort K, Sun Y, Miyakoshi M, Vanderpool CK, Vogel J. Small RNA-mediated activation of sugar phosphatase mRNA regulates glucose homeostasis. Cell 2013;153:426-37. [PMID: 23582330 DOI: 10.1016/j.cell.2013.03.003] [Cited by in Crossref: 151] [Cited by in F6Publishing: 120] [Article Influence: 18.9] [Reference Citation Analysis]
79 Zhang X, Yang S, Chen J, Su Z. Unraveling the Regulation of Hepatic Gluconeogenesis. Front Endocrinol (Lausanne). 2018;9:802. [PMID: 30733709 DOI: 10.3389/fendo.2018.00802] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 21.0] [Reference Citation Analysis]
80 Cho JH, Lee YM, Starost MF, Mansfield BC, Chou JY. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. J Inherit Metab Dis 2019;42:459-69. [PMID: 30637773 DOI: 10.1002/jimd.12056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
81 Hochuli M, Christ E, Meienberg F, Lehmann R, Krützfeldt J, Baumgartner MR. Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study. J Inherit Metab Dis 2015;38:1093-8. [DOI: 10.1007/s10545-015-9864-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhang L, Cho JH, Arnaoutova I, Mansfield BC, Chou JY. An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia. J Inherit Metab Dis 2019;42:470-9. [PMID: 30714174 DOI: 10.1002/jimd.12069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
83 Wilson LH, Cho JH, Estrella A, Smyth JA, Wu R, Chengsupanimit T, Brown LM, Weinstein DA, Lee YM. Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI. Hepatol Commun 2019;3:1544-55. [PMID: 31701076 DOI: 10.1002/hep4.1426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
84 Xu Q, Tang H, Duan L, Zuo X, Shi X, Li Y, Zhao H, Zhang H. A novel SLC37A4 missense mutation in GSD-Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis. Mol Genet Genomic Med 2021;9:e1568. [PMID: 33280276 DOI: 10.1002/mgg3.1568] [Reference Citation Analysis]
85 Farah BL, Sinha RA, Wu Y, Singh BK, Lim A, Hirayama M, Landau DJ, Bay BH, Koeberl DD, Yen PM. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa). Sci Rep. 2017;7:44408. [PMID: 28317891 DOI: 10.1038/srep44408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
86 Zhang L, Lee C, Arnaoutova I, Anduaga J, Starost MF, Mansfield BC, Chou JY. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia. Biochem Biophys Res Commun 2020;527:824-30. [PMID: 32430177 DOI: 10.1016/j.bbrc.2020.04.124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Heath RD, Ertem F, Romana BS, Ibdah JA, Tahan V. Hepatocyte transplantation: Consider infusion before incision. World J Transplant 2017;7:317-23. [PMID: 29312860 DOI: 10.5500/wjt.v7.i6.317] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Sim SW, Park TS, Kim SJ, Park BC, Weinstein DA, Lee YM, Jun HS. Aberrant proliferation and differentiation of glycogen storage disease type Ib mesenchymal stem cells. FEBS Lett 2018;592:162-71. [PMID: 29238966 DOI: 10.1002/1873-3468.12939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
89 Cho JH, Weinstein DA, Lee YM. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review. J Inherit Metab Dis 2021;44:118-28. [PMID: 32474930 DOI: 10.1002/jimd.12267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Yang M, Bose S, Lim S, Seo J, Shin J, Lee D, Chung WH, Song EJ, Nam YD, Kim H. Beneficial Effects of Newly Isolated Akkermansia muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation. Microorganisms 2020;8:E1413. [PMID: 32937828 DOI: 10.3390/microorganisms8091413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
91 Imle R, Wang BT, Stützenberger N, Birkenhagen J, Tandon A, Carl M, Himmelreich N, Thiel C, Gröne HJ, Poschet G, Völkers M, Gülow K, Schröder A, Carillo S, Mittermayr S, Bones J, Kamiński MM, Kölker S, Sauer SW. ADP-dependent glucokinase regulates energy metabolism via ER-localized glucose sensing. Sci Rep 2019;9:14248. [PMID: 31582762 DOI: 10.1038/s41598-019-50566-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
92 Lee YM, Pan CJ, Koeberl DD, Mansfield BC, Chou JY. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia. Mol Genet Metab 2013;110:275-80. [PMID: 23856420 DOI: 10.1016/j.ymgme.2013.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
93 Wang Z, Zhao Q, Nie Y, Yu Y, Misra BB, Zabalawi M, Chou JW, Key CC, Molina AJ, Quinn MA, Fessler MB, Parks JS, McCall CE, Zhu X. Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis. iScience 2020;23:101125. [PMID: 32428862 DOI: 10.1016/j.isci.2020.101125] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Farah BL, Landau DJ, Sinha RA, Brooks ED, Wu Y, Fung SYS, Tanaka T, Hirayama M, Bay BH, Koeberl DD, Yen PM. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency. J Hepatol. 2016;64:370-379. [PMID: 26462884 DOI: 10.1016/j.jhep.2015.10.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
95 Cho JH, Kim GY, Mansfield BC, Chou JY. Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia. J Inherit Metab Dis 2018. [PMID: 29740774 DOI: 10.1007/s10545-018-0192-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
96 Wang T, Xu D, Fan Q, Rong W, Zheng J, Gao C, Li G, Zeng N, Guo T, Zeng L, Wang F, Xiao C, Cai L, Tang S, Deng X, Yin X, Huang M, Lu F, Hu Q, Chen W, Huang Z, Wang Q. 1,2-Dichloroethane impairs glucose and lipid homeostasis in the livers of NIH Swiss mice. Toxicology 2017;380:38-49. [DOI: 10.1016/j.tox.2017.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
97 Chou JY, Mansfield BC. The SLC37 family of sugar-phosphate/phosphate exchangers. Curr Top Membr 2014;73:357-82. [PMID: 24745989 DOI: 10.1016/B978-0-12-800223-0.00010-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
98 Farah BL, Yen PM, Koeberl DD. Links between autophagy and disorders of glycogen metabolism - Perspectives on pathogenesis and possible treatments. Mol Genet Metab 2020;129:3-12. [PMID: 31787497 DOI: 10.1016/j.ymgme.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
99 Chou JY, Sik Jun H, Mansfield BC. The SLC37 family of phosphate-linked sugar phosphate antiporters. Mol Aspects Med 2013;34:601-11. [PMID: 23506893 DOI: 10.1016/j.mam.2012.05.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
100 Letkemann R, Wittkowski H, Antonopoulos A, Podskabi T, Haslam SM, Föll D, Dell A, Marquardt T. Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib. Int Immunopharmacol 2017;44:216-25. [PMID: 28126686 DOI: 10.1016/j.intimp.2017.01.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
101 Alsina M. [What is your diagnosis? (Cutaneous leishmaniasis)]. Med Cutan Ibero Lat Am. 1982;10:353-354. [PMID: 6764236 DOI: 10.3389/fimmu.2019.02099] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 1.2] [Reference Citation Analysis]
102 Du C, Li Z, Wei H, Zhang M, Hu M, Zhang C, Luo X, Liang Y. Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib. BMC Med Genomics 2021;14:81. [PMID: 33731098 DOI: 10.1186/s12920-021-00936-9] [Reference Citation Analysis]
103 Gautam S, Zhang L, Arnaoutova I, Lee C, Mansfield BC, Chou JY. The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia. Hum Mol Genet 2020;29:834-44. [PMID: 31961433 DOI: 10.1093/hmg/ddaa007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]